Tuteja S et al. |
The effect of gut metabolism on tacrolimus bioavailability in renal transplant recipients. |
2001 |
Transplantation |
pmid:11397967
|
Reichenspurner H et al. |
Optimization of the immunosuppressive protocol after lung transplantation. |
1999 |
Transplantation |
pmid:10428269
|
Pilmore HL et al. |
Tacrolimus for the treatment of gout in renal transplantation: two case reports and review of the literature. |
2001 |
Transplantation |
pmid:11726837
|
Tzakis AG et al. |
Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation. |
2003 |
Transplantation |
pmid:12792506
|
Hytiroglou P et al. |
FK506 versus cyclosporine as primary immunosuppressive agent for orthotopic liver allograft recipients. Histologic and immunopathologic observations. |
1993 |
Transplantation |
pmid:7506452
|
Gaber AO et al. |
Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial. |
2008 |
Transplantation |
pmid:19005398
|
Morikawa K et al. |
The distinct effects of FK506 on the activation, proliferation, and differentiation of human B lymphocytes. |
1992 |
Transplantation |
pmid:1281561
|
Berg UB et al. |
Renal function before and long after liver transplantation in children. |
2001 |
Transplantation |
pmid:11544422
|
Irish W et al. |
Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen. |
2003 |
Transplantation |
pmid:14688516
|
Gruessner RW et al. |
Mycophenolate mofetil in pancreas transplantation. |
1998 |
Transplantation |
pmid:9721799
|
Emond JC et al. |
Improved results of living-related liver transplantation with routine application in a pediatric program. |
1993 |
Transplantation |
pmid:7682738
|
Chisholm MA et al. |
Coadministration of tacrolimus with anti-acid drugs. |
2003 |
Transplantation |
pmid:12973105
|
Mourad M et al. |
Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids. |
2005 |
Transplantation |
pmid:16249748
|
Kershner RP and Fitzsimmons WE |
Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. |
1996 |
Transplantation |
pmid:8878385
|
Macedo C et al. |
Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantation. |
2012 |
Transplantation |
pmid:22343334
|
Devlin J et al. |
Nitric oxide generation. A predictive parameter of acute allograft rejection. |
1994 |
Transplantation |
pmid:7522365
|
Markus PM et al. |
Effects of in vivo treatment with FK506 on natural killer cells in rats. |
1991 |
Transplantation |
pmid:1707562
|
Fredericks S and Holt DW |
TGF-beta quantitation can be tricky. |
1999 |
Transplantation |
pmid:10480399
|
Schvarcz R et al. |
Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV). |
2000 |
Transplantation |
pmid:10852623
|
Todo S et al. |
Small intestinal transplantation in humans with or without the colon. |
1994 |
Transplantation |
pmid:7512291
|